Nitric oxide modulation of low-density mononuclear cell transendothelial migration

Area of Science:

• Endothelial biology
• Cellular physiology
• Immunology

Background:

• The blood-endothelial cell interface is crucial for physiological and pathological processes, regulating the passage of blood-borne substances and cells into tissues.
• While factors like nitric oxide (NO) and vascular endothelial growth factor (VEGF) are known to influence endothelial permeability, their roles, especially NO's in non-inflammatory states, are not fully understood.
• Understanding these mechanisms is key to modulating processes like immune cell trafficking and drug delivery.

Purpose of the Study:

• To investigate the role of nitric oxide (NO) in modulating the permeability of endothelial cell monolayers to low-density mononuclear cells (LDMNCs) in the absence of inflammatory stimuli.
• To determine if vascular endothelial growth factor (VEGF) is involved in NO-mediated effects on endothelial permeability.

Main Methods:

• Utilized a Transwell chamber model to create endothelial cell monolayers.
• Assessed the migration of LDMNCs across these monolayers under various conditions.
• Administered NO donors, L-arginine (NO precursor), nitric oxide synthase (NOS) inhibitors, and VEGF antibodies to evaluate their effects.

Main Results:

• NO donors and L-arginine significantly increased transendothelial migration of LDMNCs.
• Inhibition of NOS decreased LDMNC migration across the endothelial monolayers.
• These NO-dependent effects on cell migration were not significantly altered by the presence of VEGF antibodies.

Conclusions:

• Nitric oxide (NO) plays a significant role in increasing endothelial cell permeability to LDMNCs, independent of inflammatory conditions.
• The observed increase in cell migration is mediated by NO and does not appear to be dependent on vascular endothelial growth factor (VEGF).
• These findings highlight a novel mechanism by which NO influences immune cell trafficking in non-inflammatory settings.